Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU1987/000068external-prioritypatent/WO1987005628A1/en
Application filed by Biotech Australia Pty Ltd, Univ AustralianfiledCriticalBiotech Australia Pty Ltd
Priority to NO952506ApriorityCriticalpatent/NO952506D0/en
Publication of NO952506LpublicationCriticalpatent/NO952506L/en
Publication of NO952506D0publicationCriticalpatent/NO952506D0/en
Antistoffpreparater som er frem- stilt mot homogent minaktivin, inklu- dert homogent rekombinant minaktivin, og fragmenter derav. Anvendelse av an- tistoffene for påvisning av minaktivin i prøver av humane kroppsvæsker.Antibody preparations prepared against homogeneous minactivin, including homogeneous recombinant minactivin, and fragments thereof. Use of the antibodies for the detection of minactivin in human body fluid samples.
NO952506A1986-03-131995-06-22
Antibody preparations for homogeneous minactivin and their use for the detection of minactivin in human body fluids
NO952506D0
(en)
Method for Preparation of Minactivin, DNA Molecule, Gene, Host, Probes, Preparations Including Probes, Reagents for Localization and Definition. of limits for tumor in histological specimens, as well as the use of DNA molecule, minactivin and preparation
PROCEDURE FOR SELECTIVE IMMUNOLOGICAL DETERMINATION OF INTACT PROCOLLAGEN PEPTID (TYPE III) AND PROCOLLAGEN (TYPE III) IN BODY LIQUID, AND AGENT FOR ITS IMPLEMENTATION.
Monoclonal antibodies for the selective, immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids